Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1042 | 1103 | 1260 | 1641 | 1988 | 2055 |
| Fund Return | 4.22% | 10.26% | 26.04% | 17.95% | 14.73% | 7.47% |
| Place in category | 27 | 20 | 17 | 14 | 14 | 51 |
| % in Category | 8 | 6 | 6 | 4 | 3 | 37 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| JPM Global Income A acc EUR | 17.76B | 1.48 | 6.23 | 3.42 | ||
| LU0740858492 | 17.76B | 1.45 | 5.86 | 3.05 | ||
| JPM Global Income Fund A Mth EUR | 17.76B | 1.48 | 6.21 | 3.39 | ||
| JPMorgan Global Income D div EUR | 17.76B | 1.45 | 5.86 | 3.06 | ||
| JPMorgan Global Income A Div EUR | 17.76B | 1.48 | 6.23 | 3.42 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| LU0414045582 | 1.88B | 1.85 | 12.73 | 5.48 | ||
| Allianz Glbl Inv Euro Eq div W EUR | 1.88B | 1.95 | 14.07 | 6.74 | ||
| LU0971552913 | 1.88B | 1.85 | 12.73 | 5.49 | ||
| LU0414045822 | 1.88B | 1.85 | 12.73 | 5.48 | ||
| LU0414046390 | 1.88B | 1.79 | 11.89 | 4.69 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| ASML Holding | NL0010273215 | 3.91 | 1,161.80 | -4.02% | |
| Roche Holding Participation | CH0012032048 | 2.52 | 355.40 | -2.07% | |
| Novartis | CH0012005267 | 2.34 | 126.40 | -2.74% | |
| JPMorgan Liquidity Funds Euro Liquidity Fund X ( | LU0836346931 | 2.19 | 10,854.340 | -0.00% | |
| HSBC | GB0005405286 | 2.10 | 1,262.80 | -5.20% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review